Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation
- 1 December 2001
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 11 (6), 445-453
- https://doi.org/10.1006/scbi.2001.0411
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L ProteinPublished by Elsevier BV ,2001
- Interferon Regulatory Factor 7 Mediates Activation of Tap-2 by Epstein-Barr Virus Latent Membrane Protein 1Journal of Virology, 2001
- The interferon regulatory factors and oncogenesisSeminars in Cancer Biology, 2000
- Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaNature Genetics, 1997
- Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expressionEuropean Journal of Immunology, 1995
- Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1Cancer Letters, 1994
- Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elementsCell, 1988
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- IMMUNITY TO EPSTEIN-BARR VIRUS IN CYCLOSPORIN A-TREATED RENAL ALLOGRAFT RECIPIENTSThe Lancet, 1982
- LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORIN AThe Lancet, 1981